Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 02, 2023

BUY
$138.42 - $180.31 $2.65 Million - $3.45 Million
19,152 Added 30.4%
82,161 $11.6 Million
Q1 2023

May 12, 2023

SELL
$154.26 - $198.1 $485,919 - $624,015
-3,150 Reduced 4.76%
63,009 $10.6 Million
Q4 2022

Feb 14, 2023

BUY
$162.42 - $220.56 $10.7 Million - $14.6 Million
66,159 New
66,159 $0

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.94B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Cercano Management LLC Portfolio

Follow Cercano Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cercano Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cercano Management LLC with notifications on news.